DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
This review presents our own and literature data dedicated to predisposing and pathogenetic factors involved in development of a common comorbidity, diabetes-associated osteoarthritis (DAOA). So far, there is no wide-accepted clinical or scientific viewing of DAOA as a distinct clinical phenotype of...
Guardado en:
Autores principales: | E. V. Kazygasheva, V. S. Shirinsky, I. V. Shirinsky |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7c891acefd2f44a092f26d0461ef567c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2015) -
CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
por: V. S. Shirinsky, et al.
Publicado: (2017) -
COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
por: I. V. Shirinsky, et al.
Publicado: (2015) -
CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2016) -
INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS
por: V. S. Shirinsky, et al.
Publicado: (2019)